MS - Morgan Stanley
Supported primarily by solid first-quarter 2026 results, shares of Morgan Stanley MS have gained 13.2% so far this year, outperforming the S&P 500 Index's 9.7% growth and the industry's 2.2% decline. In the March-ended quarter, MS benefited mainly from robust client engagement and strength in investment banking (IB) and trading activities.
Here is how Morgan Stanley (MS) and Federal Agricultural Mortgage (AGM) have performed compared to their sector so far this year.
Zacks.com users have recently been watching Morgan Stanley (MS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Morgan Stanley stock is in a buy zone of a base. A biometric identity name hit a new high after rebounding following a sell signal.
Morgan Stanley is upgraded to a 'Buy', driven by robust top-line growth, margin recovery, and strong competitive positioning. Morgan Stanley demonstrates proven revenue growth, positive client inflows, and benefits from M&A and resilient equity markets, supporting its diversified business model. Despite signs of overvaluation and modest 7% upside forecasts, its A-level credit ratings, strong liquidity, and low payout ratio reinforce its quality profile.
In the most recent trading session, Morgan Stanley (MS) closed at $200.51, indicating a +1.39% shift from the previous trading day.
NEW YORK--(BUSINESS WIRE)--Morgan Stanley (NYSE: MS) today announced the winners of its 17th annual Strategy Challenge, the Firm's flagship pro bono program which brings together rising talent to help nonprofits solve strategic, mission-critical challenges. The winning teams supported Hour Children in the U.S. and Mental Health Innovations in the UK. Over the past 10 weeks, Morgan Stanley employees provided in-depth, pro bono consulting services to 14 nonprofits on topics such as expanding prog.
When tech stocks are flying high, it can be easy to forget about the steady, dividend-paying stocks that often stabilize a portfolio.
WSJ reports that Goldman Sachs will lead the SpaceX IPO next month. Fees on the IPO could exceed $1 billion and will be shared among 21 underwriting banks.
Morgan Stanley has asked its Hong Kong-based bankers to carry new mobile devices issued exclusively for business travel to mainland China, as international firms with a cross-border workforce tighten data security.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics, the architect of the Locksmith® platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead Passkey's clinical and medical strategy as it advances a series of Locksmith-identified drug combinations into clinical studies across multiple therapeutic areas. Dr. Kaur most recently served as Senior.
The financial services giant saw a 48% increase in investment banking fees in Q1.
[url="]Morgan Stanley at Work[/url] today issued new data from its sixth annual State of the Workplace Financial Benefits Study. The research reveals workpla
NEW YORK--(BUSINESS WIRE)--Morgan Stanley at Work today issued new data from its sixth annual State of the Workplace Financial Benefits Study. The research reveals workplace financial benefits are a powerful driver of employee satisfaction, engagement and retention, especially as a tighter job market, AI disruption and rising costs influence expectations for employer support. Financial stress remains a persistent challenge, fueling demand for practical planning guidance and help in maximizing e.
Kiplinger's Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide open across the entire risk spectrum. We are seeing a massive spread, with opportunities ranging from stable 3% municipal bonds to 13% for those willing to get aggressive with business development companies. This is unfolding... Kiplinger's May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
NEW YORK--(BUSINESS WIRE)--Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $292.89 per share (equivalent to $0.292888 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $450.26 per share (equivalent to $0.450260 per Depositary Share) Fix.
Morgan Stanley (MS) reported earnings 30 days ago. What's next for the stock?
Morgan Stanley Direct Lending offers an 11.9% yield and trades at a 25% discount to NAV, presenting a compelling value opportunity. MSDL's conservatively managed, diversified portfolio is 94% first-lien, with strong alignment from Morgan Stanley's 11% ownership. Growth drivers include the Capstone joint venture, improving direct lending spreads, and a recovering sponsor-backed M&A environment.
Ford's new battery‑storage arm and a bullish Wall Street call are reshaping its growth story, today, May 13, 2026.
Morgan Stanley (MS) sees more potential upside for the Chinese yuan, but the bank is taking a more measured stance than investors calling the currency deeply un